Intelligent Investor

Mesoblast Limited (ASX: MSB) - Announcements

- Current share price for MSB : $1.085

ASX company news and announcements for Mesoblast Limited (MSB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Mesoblast Limited (MSB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Mesoblast Limited (MSB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Mesoblast Limited (MSB)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$1,239 Notification regarding unquoted securities - MSB 15 Jan 2024 5:19PM $0.280 $1.085 $0.795 risen by 287.50%
$1,239 Notification of cessation of securities - MSB 15 Jan 2024 5:11PM $0.280 $1.085 $0.795 risen by 287.50%
$1,239 Appendix 3Y for Joseph Swedish 3 Jan 2024 5:23PM $0.290 $1.085 $0.795 risen by 274.14%
$1,239 Amended Appendix 3Gs for Unquoted Warrants 3 Jan 2024 5:19PM $0.290 $1.085 $0.795 risen by 274.14%
$1,239 Update on Institutional Placement and Entitlement Offer 28 Dec 2023 11:03AM $0.298 $1.085 $0.795 risen by 264.71%
$1,239 Appendix 3Ys- J Swedish,B Burns,J Bell,P Krause,P Facchina 28 Dec 2023 10:53AM $0.298 $1.085 $0.795 risen by 264.71%
$1,239 Appendix 2A 28 Dec 2023 10:50AM $0.298 $1.085 $0.795 risen by 264.71%
$1,239 Notification of cessation of securities - MSB 28 Dec 2023 10:33AM $0.300 $1.085 $0.795 risen by 261.67%
$1,239 Change of Director's Interest Notice - Silviu Itescu 12 Dec 2023 11:00AM $0.283 $1.085 $0.795 risen by 284.07%
$1,239 Institutional Placement Cleansing Notice 12 Dec 2023 10:54AM $0.285 $1.085 $0.795 risen by 280.70%
$1,239 Appendix 2A 11 Dec 2023 11:47AM $0.285 $1.085 $0.795 risen by 280.70%
$1,239 Information For Retail Shareholders 8 Dec 2023 9:03AM $0.315 $1.085 $0.795 risen by 244.44%
$1,239 Mesoblast Completes Institutional Allocation 5 Dec 2023 10:10AM $0.405 $1.085 $0.795 risen by 167.90%
$1,239 Entitlement Offer Cleansing Notice 4 Dec 2023 1:01PM $0.405 $1.085 $0.795 risen by 167.90%
$1,239 Appendix 3B Entitlement Offer and Placement 4 Dec 2023 12:53PM $0.405 $1.085 $0.795 risen by 167.90%
$1,239 Entitlement Offer and Placement Investor Presentation 4 Dec 2023 12:44PM $0.405 $1.085 $0.795 risen by 167.90%
$1,239 MSB Launches Entitlement Offer and Placement 4 Dec 2023 11:55AM $0.405 $1.085 $0.795 risen by 167.90%
$1,239 Trading Halt 1 Dec 2023 9:41AM $0.405 $1.085 $0.795 risen by 167.90%
$1,239 Amended Constitution 29 Nov 2023 5:04PM $0.415 $1.085 $0.795 risen by 161.45%
$1,239 Results of Meeting 28 Nov 2023 5:25PM $0.420 $1.085 $0.795 risen by 158.33%
$1,239 CEO Presentation to 2023 Annual General Meeting 28 Nov 2023 11:57AM $0.415 $1.085 $0.795 risen by 161.45%
$1,239 Mesoblast Chairman Message to 2023 AGM 28 Nov 2023 11:55AM $0.415 $1.085 $0.795 risen by 161.45%
$1,239 MSB Files for FDA Designations in Congenital Heart Disease 27 Nov 2023 9:55AM $0.385 $1.085 $0.795 risen by 181.82%
$1,239 Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial 22 Nov 2023 9:50AM $0.405 $1.085 $0.795 risen by 167.90%
$1,239 Mesoblast Corporate Presentation 15 Nov 2023 9:55AM $0.360 $1.085 $0.795 risen by 201.39%

26 - 50 of 906 results

Page 2 of 37

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.